Pro Share Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 7,197 shares of APLS stock, worth $205,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,197

Previous 7,492 3.94%

Holding current value

$205,186

Previous $287,000 27.87%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$28.84 - $41.15 $8,507 - $12,139	-295 Reduced 3.94%	7,197 $207,000
Q2 2024 Aug 13, 2024	SELL	$38.07 - $59.71 $36,547 - $57,321	-960 Reduced 11.36%	7,492 $287,000
Q1 2024 May 08, 2024	BUY	$55.39 - $72.47 $48,798 - $63,846	881 Added 11.64%	8,452 $496,000
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $4,493 - $7,843	-121 Reduced 1.57%	7,571 $453,000
Q3 2023 Nov 13, 2023	BUY	$23.65 - $89.22 $3,713 - $14,007	157 Added 2.08%	7,692 $292,000
Q2 2023 Aug 10, 2023	SELL	$76.68 - $93.31 $877,142 - $1.07 Million	-11,439 Reduced 60.29%	7,535 $686,000
Q1 2023 May 11, 2023	SELL	$46.59 - $66.96 $170,659 - $245,274	-3,663 Reduced 16.18%	18,974 $1.25 Million
Q4 2022 Feb 02, 2023	BUY	$43.24 - $61.04 $67,843 - $95,771	1,569 Added 7.45%	22,637 $1.17 Million
Q3 2022 Nov 04, 2022	BUY	$44.76 - $69.66 $114,496 - $178,190	2,558 Added 13.82%	21,068 $1.44 Million
Q2 2022 Aug 01, 2022	SELL	$35.07 - $59.21 $183,591 - $309,964	-5,235 Reduced 22.05%	18,510 $836,000
Q1 2022 May 10, 2022	SELL	$35.46 - $54.12 $191,696 - $292,572	-5,406 Reduced 18.54%	23,745 $1.21 Million
Q4 2021 Feb 08, 2022	BUY	$30.74 - $49.16 $69,380 - $110,954	2,257 Added 8.39%	29,151 $1.38 Million
Q3 2021 Nov 12, 2021	SELL	$31.4 - $69.84 $138,756 - $308,622	-4,419 Reduced 14.11%	26,894 $886,000
Q2 2021 Aug 13, 2021	BUY	$40.9 - $64.9 $169,080 - $268,296	4,134 Added 15.21%	31,313 $1.98 Million
Q1 2021 May 14, 2021	BUY	$40.8 - $57.39 $89,188 - $125,454	2,186 Added 8.75%	27,179 $1.17 Million
Q4 2020 Feb 09, 2021	BUY	$30.79 - $57.2 $167,682 - $311,511	5,446 Added 27.86%	24,993 $1.43 Million
Q3 2020 Nov 13, 2020	SELL	$25.89 - $33.65 $17,605 - $22,882	-680 Reduced 3.36%	19,547 $590,000
Q2 2020 Aug 03, 2020	BUY	$24.8 - $38.49 $162,960 - $252,917	6,571 Added 48.12%	20,227 $661,000
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $121,429 - $300,557	-6,780 Reduced 33.18%	13,656 $366,000
Q4 2019 Feb 12, 2020	SELL	$22.1 - $30.8 $51,117 - $71,240	-2,313 Reduced 10.17%	20,436 $626,000
Q3 2019 Nov 12, 2019	BUY	$24.09 - $32.18 $11,346 - $15,156	471 Added 2.11%	22,749 $548,000
Q2 2019 Aug 13, 2019	SELL	$18.0 - $25.34 $12,906 - $18,168	-717 Reduced 3.12%	22,278 $565,000
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $1,626 - $2,517	127 Added 0.56%	22,995 $448,000
Q4 2018 Feb 14, 2019	BUY	$11.47 - $18.71 $262,295 - $427,860	22,868 New	22,868 $302,000

Others Institutions Holding APLS

# of Institutions

304

Shares Held

109M

Call Options Held

3.87M

Put Options Held

1.12M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.13B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History